Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gwo Xi Stem Cell Applied Technology Co (ROCO:6704) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Gwo Xi Stem Cell Applied Technology Co had a gross margin of 70.88% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Gwo Xi Stem Cell Applied Technology Co Gross Margin % Related Terms
Gwo Xi Stem Cell Applied Technology Co Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gwo Xi Stem Cell Applied Technology Co Gross Margin % Chart
Gwo Xi Stem Cell Applied Technology Co Annual Data
ROCO:6704 vs VRTX, REGN, ALNY: Gross Margin % Comparison
For the Biotechnology subindustry, Gwo Xi Stem Cell Applied Technology Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gwo Xi Stem Cell Applied Technology Co Gross Margin % vs Biotechnology Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Gwo Xi Stem Cell Applied Technology Co (ROCO:6704) has a Gross Margin % of 70.88% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Gwo Xi Stem Cell Applied Technology Co and its competitors. This is near median its historical median of 69.58. Over the past decade, Gwo Xi Stem Cell Applied Technology Co's Gross Margin % has ranged from 60.73 to 88.60. According to the industry distribution chart, Gwo Xi Stem Cell Applied Technology Co ranks #289 out of 733 companies in the Biotechnology industry, placing it in the top 39.4%.
Is Gwo Xi Stem Cell Applied Technology Co's Gross Margin % too high?
Gwo Xi Stem Cell Applied Technology Co's current Gross Margin % of 70.88% is near median its 10-year median of 69.58. Over the past 10 years, this metric has ranged from a low of 60.73 to a high of 88.60. The Biotechnology industry median Gross Margin % is 60.91. Gwo Xi Stem Cell Applied Technology Co's value of 70.88% is 16.4% above this industry median. Based on the distribution chart, Gwo Xi Stem Cell Applied Technology Co ranks #289 out of 733 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Gwo Xi Stem Cell Applied Technology Co has a GF Score™ of 39/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gwo Xi Stem Cell Applied Technology Co's Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Gwo Xi Stem Cell Applied Technology Co ranks #289 out of 733 companies for Gross Margin %. This puts Gwo Xi Stem Cell Applied Technology Co in the upper half of its industry. The industry median Gross Margin % is 60.91. Gwo Xi Stem Cell Applied Technology Co's value of 70.88% is 16.4% above this benchmark. Historically, Gwo Xi Stem Cell Applied Technology Co's own Gross Margin % has ranged from 60.73 to 88.60 over the past decade. While the company's 10-year median is 69.58 vs. the industry median of 60.91, Gwo Xi Stem Cell Applied Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.91, based on 733 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gwo Xi Stem Cell Applied Technology Co's current Gross Margin % of 70.88% is 16.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Gwo Xi Stem Cell Applied Technology Co and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gwo Xi Stem Cell Applied Technology Co's current Gross Margin % is 70.88%, which is near median its own 10-year median of 69.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gwo Xi Stem Cell Applied Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Gwo Xi Stem Cell Applied Technology Co (ROCO:6704) is currently considered Possible Value Trap. The stock's GF Value™ is NT$35.51, compared to a current price of NT$19.15 — trading 46.1% below its estimated fair value. The current Gross Margin % is 70.88%, which is near median its 10-year median of 69.58 and 16.4% above the Biotechnology industry median of 60.91. Gwo Xi Stem Cell Applied Technology Co's overall GF Score™ is 39/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Gwo Xi Stem Cell Applied Technology Co (ROCO:6704), the current Gross Margin % is 70.88% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gwo Xi Stem Cell Applied Technology Co (ROCO:6704) Overvalued in 2026?
Based on GuruFocus' analysis, Gwo Xi Stem Cell Applied Technology Co stock appears to be undervalued.
The current stock price of NT$19.15 is trading 46.1% below its estimated GF Value™ of NT$35.51.
GuruFocus considers Gwo Xi Stem Cell Applied Technology Co to be Possible Value Trap.
Key valuation signals for ROCO:6704:
Gross Margin %: 70.88% (near median its 10-year median of 69.58)
GF Value™: NT$35.51 vs. price of NT$19.15 (46.1% below fair value)
Industry Position: 16.4% above the Biotechnology median (#289 of 733)
No single metric tells the full story. See the ROCO:6704 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gwo Xi Stem Cell Applied Technology Co Business Description
Gwo Xi Stem Cell Applied Technology Co is committed to developing stem cell medicines that have the potential to help patients with unmet medical needs.
39GF Score
Get the complete analysis for ROCO:6704
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6704 has been successfully added to your 
